接受择期腹主动脉腔内修复术的八旬以上患者围手术期及远期生存的预测因素
研究前瞻性评估2006至2015年1135例择期EVAR中201例80岁以上患者的30天及远期生存,30天死亡率为2%,ASA评分4分(OR 12.7)和PAOD(HR 3.07)是中远期死亡的独立预测因素,无或仅一项危险因素者生存率支持治疗。
要点
- 80岁以上患者择期EVAR的30天死亡率为2%(n=4)。
- ASA评分4分者30天死亡率9.4%,显著高于ASA评分<4分者的0.6%。
- ASA评分4分和PAOD是中远期死亡的独立预测因素。
核心结论
- 80岁以上患者行EVAR的总体早期死亡率低至2%;无或仅有一项危险因素者生存率支持治疗腹主动脉瘤,而同时有ASA评分4分和PAOD者死亡率显著更高且预期寿命缩短。
研究设计与样本
- 前瞻性评估2006至2015年所有连续接受择期EVAR的80岁以上患者,共201例(占10年间1135例EVAR的18%),中位年龄84岁(四分位距3岁),85%为男性。
主要发现
- 总体30天死亡率为2%(n=4),ASA评分4分者30天死亡率9.4%,显著高于ASA评分<4分者的0.6%(P=.04),多因素分析证实(OR 12.7;95%CI 1.1-141.8;P=.04)。
- 平均随访36±18个月,1年、3年和5年总体生存率分别为85%±2%、77%±3%和52%±4%。
- 多因素Cox回归显示,ASA评分4分(HR 2.0;95%CI 1.2-2.9;P=.04)和PAOD(HR 3.07;95%CI 1.06-5.2;P=.04)是中远期死亡的独立预测因素。
- 2年生存率受两项独立预测因素影响:同时有ASA评分4分和PAOD者为33%±2%,有其中一项者为67%±8%,两者均无者为92%±3%(P=.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The appropriateness of endovascular aneurysm repair (EVAR) of uncomplicated abdominal aortic aneurysm depends on the risk-benefit ratio, particularly in elderly patients with short life expectancy. The aim of this study was to assess the efficacy of EVAR in >80-year-old patients by evaluating their postoperative survival and analyzing the possible predictors of late mortality. METHODS: All consecutive patients aged >80 years undergoing elective EVAR from 2006 to 2015 were prospectively evaluated. The 30-day mortality and long-term survival were assessed, and independent risk factors for mortality were determined by multivariate logistic and Cox analysis. RESULTS: Of a total of 1135 EVARs performed in a 10-year period, 201 (18%) occurred in patients older than 80 years. The median age was 84 years (interquartile range, 3 years), and 85% were male. Thirty-four patients (17%) had a score of 4 according to the American Society of Anesthesiologists (ASA) classification. Overall 30-day mortality was 2% (n = 4); it was significantly higher in those with ASA score of 4 compared with ASA score <4 (9.4% vs 0.6%; P = .04) and was also confirmed by multivariate analysis (odds ratio, 12.7; 95% confidence interval [CI], 1.1-141.8; P = .04). The mean follow-up was 36 ± 18 months, and the overall survival at 1 year, 3 years, and 5 years was 85% ± 2%, 77% ± 3%, and 52% ± 4%, respectively. Using multivariate Cox regression, ASA score of 4 and peripheral artery obstructive disease (PAOD) were the only independent predictors for midterm mortality (hazard ratio of 2.0 [95% CI, 1.2-2.9; P = .04] and 3.07 [95% CI, 1.06-5.2; P = .04], respectively). The 2-year survival was significantly influenced by the presence of both (ASA score of 4 and PAOD; survival, 33% ± 2%) or one (ASA score of 4 or PAOD; survival, 67% ± 8%) of the two independent predictors. If neither ASA score of 4 nor PAOD was present, survival was significantly improved (92% ± 3%; P = .02). CONCLUSIONS: The performance of EVAR in >80-year-old patients is associated with an overall early mortality rate as low as 2%. In patients with no or only one risk factor, the survival rate warrants the treatment of abdominal aortic aneurysm; in contrast, patients with ASA score of 4 and PAOD have a significantly higher mortality rate and reduction of life expectancy.
引用
- Pini R, Gallitto E, Faggioli G, et al. Predictors of perioperative and late survival in octogenarians undergoing elective endovascular abdominal aortic repair. J Vasc Surg. 2018. PMID: 30477940. doi:10.1016/j.jvs.2018.07.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。